SEC Form 4 · accession 0001610717-26-000391
10x Genomics, Inc. · TXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Taich
Officer — Chief Financial Officer
Period of report
Aug 24, 2026
Accepted (ET)
Aug 26, 2026 · 4:44 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770787
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Aug 24, 2026 | S | 17,166 | $63.023 | D | 362,732 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- F2This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.73, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.